Cure My Disease

Don't miss your cure!

 Log in / Sign up

Snakehead fish and turmeric: a kitchen remedy put to the test against cancer-related malnutrition

NCT ID NCT07722156

Symptom relief Sponsor: DINA KEUMALA SARI Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial investigates whether a daily supplement of Channa striata (snakehead fish) and curcuma (turmeric) can improve nutritional status, reduce inflammation, and enhance quality of life in women with breast cancer undergoing chemotherapy. Over one month, 76 participants will receive either the supplement or a placebo. The study measures changes in body mass index, blood levels of the inflammatory marker interleukin-6, and self-reported well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a dietary supplement containing Channa striata (snakehead fish) and curcuma (turmeric)
What this could lead to
If it works, this could offer a simple, low-cost nutritional supplement to help breast cancer patients maintain weight, reduce inflammation, and feel better during chemotherapy.
What could go wrong
This is a small, early-stage trial with only 76 participants over one month. The supplement may show no meaningful benefit over placebo, and individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 76 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients with breast cancer aged ≥18 years who were undergoing chemotherapy. * Patients with a body mass index (BMI) of 18-29 kg/m². * Patients currently receiving chemotherapy for breast cancer. * Patients with serum albumin levels of 2.0-3.5 g/dL. * Patients who were able to consume oral food and were willing to participate in the study by providing written informed consent. Exclusion Criteria: * Patients with chronic kidney disease, renal failure, or kidney infection. * Patients with a known allergy to fish or Channa striata (snakehead fish) albumin-derived products. * Patients receiving other protein or amino acid supplements during the study period. * Patients who were non-compliant or discontinued the intervention before completion of the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nutrition Department

    Medan, North Sumatera, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.